GFAP and early-onset autosomal dominant Alzheimer disease: Also in other neurodegenerative conditions such as Alzheimer ́s disease (AD), blood GFAP appears to be superior to CSF levels in terms of reflecting Aβ pathology, especially at the early stages of the AD continuum [45].